TD Asset Management
CVS icon

TD Asset Management’s CVS Health CVS Stock Holding History

TD Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.1M Sell
1,212,485
-12,472
-1% -$961K 0.07% 210
2025
Q4 		$97.2M Sell
1,224,957
-38,412
-3% -$3.03M 0.08% 199
2025
Q3 		$95.2M Buy
1,263,369
+42,408
+3% +$2.91M 0.08% 206
2025
Q2 		$84.2M Buy
1,220,961
+155,993
+15% +$10.2M 0.07% 220
2025
Q1 		$72.2M Buy
1,064,968
+274,164
+35% +$16.4M 0.07% 245
2024
Q4 		$35.5M Sell
790,804
-281,581
-26% -$15.8M 0.03% 383
2024
Q3 		$65.8M Buy
1,072,385
+179,742
+20% +$10.5M 0.06% 270
2024
Q2 		$52.7M Sell
892,643
-327,284
-27% -$20.5M 0.05% 290
2024
Q1 		$97.3M Buy
1,219,927
+97,738
+9% +$7.47M 0.09% 203
2023
Q4 		$88.6M Buy
1,122,189
+48,229
+4% +$3.43M 0.09% 204
2023
Q3 		$75M Sell
1,073,960
-79,897
-7% -$5.66M 0.09% 178
2023
Q2 		$79.8M Sell
1,153,857
-8,269
-0.7% -$588K 0.09% 168
2023
Q1 		$86.4M Buy
1,162,126
+83,694
+8% +$7.02M 0.1% 163
2022
Q4 		$100M Buy
1,078,432
+102,729
+11% +$9.91M 0.12% 143
2022
Q3 		$94.6M Sell
975,703
-41,444
-4% -$4.1M 0.12% 142
2022
Q2 		$94.2M Buy
1,017,147
+13,924
+1% +$1.36M 0.11% 155
2022
Q1 		$102M Sell
1,003,223
-24,419
-2% -$2.57M 0.09% 172
2021
Q4 		$106M Buy
1,027,642
+21,153
+2% +$1.95M 0.09% 183
2021
Q3 		$85.4M Sell
1,006,489
-14,873
-1% -$1.25M 0.09% 183
2021
Q2 		$84.1M Buy
1,021,362
+7,887
+0.8% +$646K 0.09% 194
2021
Q1 		$76.2M Buy
1,013,475
+184,418
+22% +$13.4M 0.09% 190
2020
Q4 		$56.6M Buy
829,057
+186,549
+29% +$12.1M 0.07% 223
2020
Q3 		$37.5M Buy
642,508
+114,116
+22% +$7.1M 0.05% 261
2020
Q2 		$34.3M Sell
528,392
-7,640
-1% -$481K 0.05% 259
2020
Q1 		$31.8M Sell
536,032
-15,960
-3% -$1.07M 0.05% 244
2019
Q4 		$41M Sell
551,992
-45,731
-8% -$3.21M 0.06% 250
2019
Q3 		$37.7M Sell
597,723
-190,375
-24% -$11.3M 0.06% 260
2019
Q2 		$42.9M Sell
788,098
-64,007
-8% -$3.45M 0.06% 229
2019
Q1 		$46M Sell
852,105
-1,186,747
-58% -$73.2M 0.07% 216
2018
Q4 		$134M Buy
2,038,852
+1,285,916
+171% +$96M 0.23% 82
2018
Q3 		$59.3M Buy
752,936
+73,896
+11% +$5.28M 0.09% 189
2018
Q2 		$43.7M Sell
679,040
-71,889
-10% -$4.74M 0.07% 230
2018
Q1 		$46.7M Buy
750,929
+76,858
+11% +$5.51M 0.07% 218
2017
Q4 		$48.9M Sell
674,071
-99,133
-13% -$7.21M 0.07% 214
2017
Q3 		$62.9M Buy
773,204
+206,136
+36% +$16.3M 0.09% 168
2017
Q2 		$45.6M Buy
567,068
+13,739
+2% +$1.08M 0.07% 222
2017
Q1 		$43.4M Sell
553,329
-4,152
-0.7% -$331K 0.07% 220
2016
Q4 		$44M Sell
557,481
-848,390
-60% -$68.6M 0.07% 214
2016
Q3 		$125M Sell
1,405,871
-256,976
-15% -$24.3M 0.22% 95
2016
Q2 		$159M Sell
1,662,847
-63,858
-4% -$6.36M 0.29% 77
2016
Q1 		$179M Sell
1,726,705
-1,068,409
-38% -$104M 0.33% 59
2015
Q4 		$273M Sell
2,795,114
-65,695
-2% -$6.43M 0.54% 36
2015
Q3 		$276M Sell
2,860,809
-174,003
-6% -$18.3M 0.54% 36
2015
Q2 		$318M Sell
3,034,812
-57,601
-2% -$5.89M 0.57% 34
2015
Q1 		$319M Sell
3,092,413
-795,748
-20% -$80.5M 0.58% 34
2014
Q4 		$374M Buy
3,888,161
+40,215
+1% +$3.54M 0.62% 29
2014
Q3 		$306M Buy
3,847,946
+19,830
+0.5% +$1.56M 0.53% 34
2014
Q2 		$289M Buy
3,828,116
+143,440
+4% +$10.8M 0.49% 38
2014
Q1 		$276M Buy
3,684,676
+273,028
+8% +$19.3M 0.5% 37
2013
Q4 		$244M Buy
3,411,648
+277,745
+9% +$17.8M 0.46% 43
2013
Q3 		$178M Buy
3,133,903
+836,348
+36% +$49.8M 0.35% 52
2013
Q2 		$131M Buy
+2,297,555
New +$133M 0.28% 69

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TD Asset Management's CVS Position: Q1 2026 in Review

TD Asset Management reduced its CVS Health (CVS) stake by 1% in Q1 2026, selling an estimated $961K and leaving 1,212,485 shares worth $87.1M. The position accounts for 0.07% of the portfolio, ranked #210.

TD Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $374M in Q4 2014. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • TD Asset Management held 1,212,485 shares of CVS Health worth $87.1M as of Q1 2026.
  • TD Asset Management sold 12,472 CVS Health shares in Q1 2026, an estimated $961K.
  • CVS Health made up 0.07% of TD Asset Management's portfolio in Q1 2026, its #210 holding.
  • TD Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's CVS Health position peaked at $374M in Q4 2014.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.